Phylogeny, in situ hybridization service Sign up for PNAS Online eTocs
Link: Info for AuthorsLink: Editorial BoardLink: AboutLink: SubscribeLink: AdvertiseLink: ContactLink: Sitemap Link: PNAS Home
Proceedings of the National Academy of Sciences
Link: Current Issue "" Link: Archives "" Link: Online Submission ""  Link: Advanced Search


PNAS | August 14, 2001 | vol. 98 | no. 17 | 9808-9813
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via ISI Web of Science (117)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chang, J.-G.
Right arrow Articles by Li, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, J.-G.
Right arrow Articles by Li, H.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg  
What's this?

 Previous Article  | Table of Contents |  Next Article 

Medical Sciences
 Treatment of spinal muscular atrophy by sodium butyrate

Jan-Gowth Chang*,dagger , Hsiu-Mei Hsieh-LiDagger , Yuh-Jyh Jong§, Nancy M. Wang*, Chang-Hai Tsai*, and Hung Lidagger ,Dagger

* Department of Medical Research, China Medical College Hospital, Taichung 404, Taiwan; Dagger  Institute of Molecular Biology, Academia Sinica, Taipei 115, Taiwan; and § Departments of Pediatrics and Clinical Laboratory, Kaohsiung Medical University, Kaohsiung 807, Taiwan

Edited by Yuet Wai Kan, University of California, San Francisco, CA, and approved June 18, 2001 (received for review March 2, 2001)

Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by degeneration of the anterior horn cells of the spinal cord, leading to muscular paralysis with muscular atrophy. No effective treatment of this disorder is presently available. Studies of the correlation between disease severity and the amount of survival motor neuron (SMN) protein have shown an inverse relationship. We report that sodium butyrate effectively increases the amount of exon 7-containing SMN protein in SMA lymphoid cell lines by changing the alternative splicing pattern of exon 7 in the SMN2 gene. In vivo, sodium butyrate treatment of SMA-like mice resulted in increased expression of SMN protein in motor neurons of the spinal cord and resulted in significant improvement of SMA clinical symptoms. Oral administration of sodium butyrate to intercrosses of heterozygous pregnant knockout-transgenic SMA-like mice decreased the birth rate of severe types of SMA-like mice, and SMA symptoms were ameliorated for all three types of SMA-like mice. These results suggest that sodium butyrate may be an effective drug for the treatment of human SMA patients.

dagger To whom reprint requests should be addressed. E-mail: d6781{at}www.cmch.org.tw or hungli{at}ccvax.sinica.edu.tw.

www.pnas.org/cgi/doi/10.1073/pnas.171105098
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg    What's this?


This article has been cited by other articles in HighWire Press-hosted journals:


Home page
 Hum Mol GenetHome page
V. M. Howell, J. M. Jones, S. K. Bergren, L. Li, A. C. Billi, M. R. Avenarius, and M. H. Meisler
Evidence for a direct role of the disease modifier SCNM1 in splicing
Hum. Mol. Genet., October 15, 2007; 16(20): 2506 - 2516.
[Abstract] [Full Text] [PDF]

Home page
 J Child NeurolHome page
K. J. Swoboda, J. T. Kissel, T. O. Crawford, M. B. Bromberg, G. Acsadi, G. D'Anjou, K. J. Krosschell, S. P. Reyna, M. K. Schroth, C. B. Scott, et al.
Perspectives on Clinical Trials in Spinal Muscular Atrophy
J Child Neurol, August 1, 2007; 22(8): 957 - 966.
[Abstract] [PDF]

Home page
 J Child NeurolHome page
C. J. Sumner
Molecular Mechanisms of Spinal Muscular Atrophy
J Child Neurol, August 1, 2007; 22(8): 979 - 989.
[Abstract] [PDF]

Home page
 Hum Mol GenetHome page
C.-H. Ting, C.-W. Lin, S.-L. Wen, H.-M. Hsieh-Li, and H. Li
Stat5 constitutive activation rescues defects in spinal muscular atrophy
Hum. Mol. Genet., March 1, 2007; 16(5): 499 - 514.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
L. R. Simard, M-C Belanger, S. Morissette, M. Wride, T. W. Prior, and K. J. Swoboda
Preclinical validation of a multiplex real-time assay to quantify SMN mRNA in patients with SMA
Neurology, February 6, 2007; 68(6): 451 - 456.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
G. Faraco, T. Pancani, L. Formentini, P. Mascagni, G. Fossati, F. Leoni, F. Moroni, and A. Chiarugi
Pharmacological Inhibition of Histone Deacetylases by Suberoylanilide Hydroxamic Acid Specifically Alters Gene Expression and Reduces Ischemic Injury in the Mouse Brain
Mol. Pharmacol., December 1, 2006; 70(6): 1876 - 1884.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. J. Sumner, S. J. Kolb, G. G. Harmison, N. O. Jeffries, K. Schadt, R. S. Finkel, G. Dreyfuss, and K. H. Fischbeck
SMN mRNA and protein levels in peripheral blood: Biomarkers for SMA clinical trials
Neurology, April 11, 2006; 66(7): 1067 - 1073.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
H.-Y. Kao, Y.-N. Su, H.-K. Liao, M. S. Liu, and Y.-J. Chen
Determination of SMN1/SMN2 Gene Dosage by a Quantitative Genotyping Platform Combining Capillary Electrophoresis and MALDI-TOF Mass Spectrometry
Clin. Chem., March 1, 2006; 52(3): 361 - 369.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
D. Hirtz, S. Iannaccone, J. Heemskerk, K. Gwinn-Hardy, R. Moxley III, and L. P. Rowland
Challenges and opportunities in clinical trials for spinal muscular atrophy
Neurology, November 8, 2005; 65(9): 1352 - 1357.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
C. Grondard, O. Biondi, A.-S. Armand, S. Lecolle, B. D. Gaspera, C. Pariset, H. Li, C.-L. Gallien, P.-P. Vidal, C. Chanoine, et al.
Regular Exercise Prolongs Survival in a Type 2 Spinal Muscular Atrophy Model Mouse
J. Neurosci., August 17, 2005; 25(33): 7615 - 7622.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
J. Jarecki, X. Chen, A. Bernardino, D. D. Coovert, M. Whitney, A. Burghes, J. Stack, and B. A. Pollok
Diverse small-molecule modulators of SMN expression found by high-throughput compound screening: early leads towards a therapeutic for spinal muscular atrophy
Hum. Mol. Genet., July 15, 2005; 14(14): 2003 - 2018.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Soret, N. Bakkour, S. Maire, S. Durand, L. Zekri, M. Gabut, W. Fic, G. Divita, C. Rivalle, D. Dauzonne, et al.
Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors
PNAS, June 14, 2005; 102(24): 8764 - 8769.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. E. Kernochan, M. L. Russo, N. S. Woodling, T. N. Huynh, A. M. Avila, K. H. Fischbeck, and C. J. Sumner
The role of histone acetylation in SMN gene expression
Hum. Mol. Genet., May 1, 2005; 14(9): 1171 - 1182.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
E. C. Wolstencroft, V. Mattis, A. A. Bajer, P. J. Young, and C. L. Lorson
A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels
Hum. Mol. Genet., May 1, 2005; 14(9): 1199 - 1210.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
J. Tazi, N. Bakkour, J. Soret, L. Zekri, B. Hazra, W. Laine, B. Baldeyrou, A. Lansiaux, and C. Bailly
Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin Derivatives
Mol. Pharmacol., April 1, 2005; 67(4): 1186 - 1194.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
T. T. Le, L. T. Pham, M. E.R. Butchbach, H. L. Zhang, U. R. Monani, D. D. Coovert, T. O. Gavrilina, L. Xing, G. J. Bassell, and A. H.M. Burghes
SMN{Delta}7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN
Hum. Mol. Genet., March 15, 2005; 14(6): 845 - 857.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
I. G. Bruno, W. Jin, and G. J. Cote
Correction of aberrant FGFR1 alternative RNA splicing through targeting of intronic regulatory elements
Hum. Mol. Genet., October 1, 2004; 13(20): 2409 - 2420.
[Abstract] [Full Text] [PDF]

Home page
 RNAHome page
N. N. SINGH, E. J. ANDROPHY, and R. N. SINGH
In vivo selection reveals combinatorial controls that define a critical exon in the spinal muscular atrophy genes
RNA, August 1, 2004; 10(8): 1291 - 1305.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Muraki, B. Ohkawara, T. Hosoya, H. Onogi, J. Koizumi, T. Koizumi, K. Sumi, J.-i. Yomoda, M. V. Murray, H. Kimura, et al.
Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks
J. Biol. Chem., June 4, 2004; 279(23): 24246 - 24254.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
M. Minamiyama, M. Katsuno, H. Adachi, M. Waza, C. Sang, Y. Kobayashi, F. Tanaka, M. Doyu, A. Inukai, and G. Sobue
Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy
Hum. Mol. Genet., June 1, 2004; 13(11): 1183 - 1192.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
S. Majumder, S. Varadharaj, K. Ghoshal, U. Monani, A. H. M. Burghes, and S. T. Jacob
Identification of a Novel Cyclic AMP-response Element (CRE-II) and the Role of CREB-1 in the cAMP-induced Expression of the Survival Motor Neuron (SMN) Gene
J. Biol. Chem., April 9, 2004; 279(15): 14803 - 14811.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. A. Slaugenhaupt, J. Mull, M. Leyne, M. P. Cuajungco, S. P. Gill, M. M. Hims, F. Quintero, F. B. Axelrod, and J. F. Gusella
Rescue of a human mRNA splicing defect by the plant cytokinin kinetin
Hum. Mol. Genet., February 15, 2004; 13(4): 429 - 436.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
L. Brichta, Y. Hofmann, E. Hahnen, F. A. Siebzehnrubl, H. Raschke, I. Blumcke, I. Y. Eyupoglu, and B. Wirth
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
Hum. Mol. Genet., October 1, 2003; 12(19): 2481 - 2489.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
I. Aznarez, E. M. Chan, J. Zielenski, B. J. Blencowe, and L.-C. Tsui
Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene
Hum. Mol. Genet., August 15, 2003; 12(16): 2031 - 2040.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. T. Iannaccone and L. S. Hynan
Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy
Arch Neurol, August 1, 2003; 60(8): 1130 - 1136.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
L. A. Skordis, M. G. Dunckley, B. Yue, I. C. Eperon, and F. Muntoni
Bifunctional antisense oligonucleotides provide a trans-acting splicing enhancer that stimulates SMN2 gene expression in patient fibroblasts
PNAS, April 1, 2003; 100(7): 4114 - 4119.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Biol.Home page
U. R. Monani, M. T. Pastore, T. O. Gavrilina, S. Jablonka, T. T. Le, C. Andreassi, J. M. DiCocco, C. Lorson, E. J. Androphy, M. Sendtner, et al.
A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy
J. Cell Biol., January 2, 2003; 160(1): 41 - 52.
[Abstract] [Full Text] [PDF]

Home page
 J. Mol. Diagn.Home page
S. Ogino and R. B. Wilson
Quantification of PCR Bias Caused by a Single Nucleotide Polymorphism in SMN Gene Dosage Analysis
J. Mol. Diagn., November 1, 2002; 4(4): 185 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
S. Stamm
Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome
Hum. Mol. Genet., October 1, 2002; 11(20): 2409 - 2416.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
S. T. Iannaccone and and the American Spinal Muscular Atrophy Randomize
Outcome Measures for Pediatric Spinal Muscular Atrophy
Arch Neurol, September 1, 2002; 59(9): 1445 - 1450.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Andreassi, J. Jarecki, J. Zhou, D. D. Coovert, U. R. Monani, X. Chen, M. Whitney, B. Pollok, M. Zhang, E. Androphy, et al.
Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients
Hum. Mol. Genet., November 1, 2001; 10(24): 2841 - 2849.
[Abstract] [Full Text] [PDF]